{
    "clinical_study": {
        "@rank": "65379", 
        "acronym": "EarlyRRT", 
        "arm_group": [
            {
                "arm_group_label": "High NGAL and early RRT", 
                "arm_group_type": "Experimental", 
                "description": "NGAL level > 400 ng/ml and start continuous renal replacement therapy early"
            }, 
            {
                "arm_group_label": "High NGAL and late RRT", 
                "arm_group_type": "Experimental", 
                "description": "NGAL > 400 ng/ml and start continuous renal replacement therapy late"
            }, 
            {
                "arm_group_label": "Low NGAL", 
                "arm_group_type": "Active Comparator", 
                "description": "NGAL < 400 ng/ml and starting continuous renal replacement therapy follow with absolute indication"
            }
        ], 
        "brief_summary": {
            "textblock": "This research project is a prospective study  to compare mortality between early renal\n      replacement therapy (RRT) and  late renal replacement therapy by using plasma neutrophil\n      gelatinase associated lipocalin (pNGAL) as a tool in decision- making."
        }, 
        "brief_title": "Early Renal Replacement Therapy and the Outcome of Acute Kidney Injury", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Renal Failure", 
        "condition_browse": {
            "mesh_term": [
                "Acute Kidney Injury", 
                "Renal Insufficiency"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The patient must have given his/her informed and signed consent\n\n          -  patients with acute kidney injury in the intensive care ward.\n\n        Exclusion Criteria:\n\n          -  The patient refuses to sign the consent\n\n          -  The patient is pregnant, parturient, or breastfeeding\n\n          -  End stage renal disease\n\n          -  Chronic renal failure\n\n          -  previous kidney transplant"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01819038", 
            "org_study_id": "chula"
        }, 
        "intervention": {
            "arm_group_label": [
                "High NGAL and early RRT", 
                "High NGAL and late RRT", 
                "Low NGAL"
            ], 
            "intervention_name": "continuous renal replacement therapy", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 22, 2013", 
        "location": {
            "contact": {
                "email": "drchotima@gmail.com", 
                "last_name": "Chotima Saetia, M.D.", 
                "phone": "66875151513"
            }, 
            "facility": {
                "address": {
                    "city": "Bangkok", 
                    "country": "Thailand", 
                    "zip": "10330"
                }, 
                "name": "King Chulalongkorn Memorial Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_arms": "3", 
        "other_outcome": {
            "measure": "hemodialysis free-days", 
            "safety_issue": "Yes", 
            "time_frame": "28 days"
        }, 
        "overall_contact": {
            "email": "drnattachai@yahoo.com", 
            "last_name": "Nattachai Srisawat, M.D.", 
            "phone": "66818361891"
        }, 
        "overall_official": {
            "affiliation": "Chulalongkorn University", 
            "last_name": "Nattachai Srisawat, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Thailand: Ethical Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "mortality rate", 
            "safety_issue": "Yes", 
            "time_frame": "28 day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01819038"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Chulalongkorn University", 
            "investigator_full_name": "Nattachai Srisawat ,M.D.", 
            "investigator_title": "Principle Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "ventilator free-days", 
            "safety_issue": "Yes", 
            "time_frame": "28 days"
        }, 
        "source": "Chulalongkorn University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chulalongkorn University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}